Portfolio Co Investors 2026 for Novartis Venture Fund: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Novartis Venture Fund accounts for 36 tracked companies with verified cap-table data, 36 of which disclose round sizes totalling $4.7B. The median disclosed raise is $100M, and the largest is Merus at $500M, ahead of Catalym ($319M) and Atalanta Therapeutics ($262M).
The names that recur most often on these co-invested cap tables are Novartis Venture Fund (36 companies), Forbion (9 companies), Omega Funds (6 companies), Pfizer Ventures (6 companies), Versant Ventures (5 companies), M Ventures (4 companies). By latest disclosed round, the market skews Series A (15), Series B (13), Series D (3), IPO (2).
Companies tracked: 36
Disclosed funding total: $4.7B across 36 companies
Median disclosed raise: $100M
Largest raise: Merus — $500M
Stage mix: Series A 15 · Series B 13 · Series D 3 · IPO 2
